EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Evaluation of Indolizine Derivatives as Nonclassical Ferroptosis Inhibitors with Efficacy in Acute Liver Injury and Ischemic Stroke Models

Yijing Shu, Yuheng Jiang, Ying Xiong iD, Sheng Huang, Chen Lunjie, Wen Ye, Yao Jian, Yimou Gong iD, Bowen Lei iD, Dong Yi iD, Dan Zhang, An Guo Wu und 3 weitere

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.5c03439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Yijing Shu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Green Pharmaceutical Technology Key Laboratory of Luzhou City, School of Pharmacy, Southwest Medical University, Luzhou 646000, P.R. China. Hauptthemen laut MEDLINE: Ferroptosis, Drug Design, Indolizines, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Southwest Medical University, Science and Technology Department of Sichuan Province, Luzhou Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is a regulated form of cell death driven by iron-dependent lipid peroxidation. Inhibiting ferroptosis has emerged as a promising therapeutic strategy, but existing inhibitors suffer from limited chemical diversity and suboptimal drug-likeness. Here, we report 1,3-disubstituted indolizine derivatives as novel noncanonical ferroptosis inhibitors. Through phenotypic screening and SAR optimization, we identified D12 (3-(2-methylbenzoyl)indolizine-1-yl acetate). D12 exhibits nanomolar potency (EC50 = 39.7 nM) in RSL3/erastin-induced PC12 cells, outperforming Fer-1. Mechanistically, D12 acts independently of iron chelation, radical trapping, or direct Nrf2 activation; instead, it alleviates oxidative stress and lipid peroxidation upstream. Compared to Fer-1, D12 displays improved metabolic stability, markedly higher systemic exposure, and robust brain penetration (brain/plasma ratio = 6.31). In vivo, D12 attenuates acetaminophen-induced liver injury and cerebral ischemia-reperfusion injury. These findings establish D12 as a mechanistically distinct, drug-like preclinical candidate and. highlight the indolizine scaffold as a promising new chemotype for ferroptosis-targeted drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisDrug DesignIndolizinesChemical and Drug Induced Liver InjuryStrokeBrain IschemiaAnimalsRatsPC12 CellsStructure-Activity RelationshipHumansLipid PeroxidationOxidative StressMaleRats, Sprague-DawleyDisease Models, Animal

Substanzen

Indolizinesindolizine

Autor:innen und Institutionen

  • Green Pharmaceutical Technology Key Laboratory of Luzhou City, School of Pharmacy, Southwest Medical University, Luzhou 646000, P.R. China.
  • School of Pharmacy, Department of Pharmacy of Traditional Chinese Medicine, Southwest Medical University, Luzhou 646000, P.R. China.
  • Sichuan Key Medical Laboratory of New Drug Discovery and Drugability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Key Laboratory of Medical Electrophysi…
  • Central Nervous System Product Research and Development Key Laboratory of Sichuan Province, Southwest Medical University, Luzhou 646000, P.R. China.

ORCID-Profile: Ying Xiong, Yimou Gong, Bowen Lei, Dong Yi, Xia Zhou

Förderung

  • Southwest Medical University
  • Science and Technology Department of Sichuan Province
  • Luzhou Science and Technology Bureau
  • National Natural Science Foundation of China
  • Central Nervous System Product Research and Development Key Laboratory of Sichuan Province, Sichuan Credit Pharmaceutical CO., Ltd.

Zitieren

APA

Shu, Y., Jiang, Y., Xiong, Y., Huang, S., Lunjie, C., Ye, W., Jian, Y., Gong, Y., Lei, B., Yi, D., Zhang, D., Wu, A. G., Wei, S., Fu, Q., & Zhou, X. (2026). Design, Synthesis, and Evaluation of Indolizine Derivatives as Nonclassical Ferroptosis Inhibitors with Efficacy in Acute Liver Injury and Ischemic Stroke Models. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c03439

Vancouver

Shu Y, Jiang Y, Xiong Y, Huang S, Lunjie C, Ye W, et al. Design, Synthesis, and Evaluation of Indolizine Derivatives as Nonclassical Ferroptosis Inhibitors with Efficacy in Acute Liver Injury and Ischemic Stroke Models. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c03439

BibTeX
@article{Shu2026,
  author = {Shu, Yijing and Jiang, Yuheng and Xiong, Ying and Huang, Sheng and Lunjie, Chen and Ye, Wen and Jian, Yao and Gong, Yimou and Lei, Bowen and Yi, Dong and Zhang, Dan and Wu, An Guo and Wei, Siping and Fu, Qiang and Zhou, Xia},
  title = {Design, Synthesis, and Evaluation of Indolizine Derivatives as Nonclassical Ferroptosis Inhibitors with Efficacy in Acute Liver Injury and Ischemic Stroke Models},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.5c03439}
}
Kostenlos starten →